Search

Your search keyword '"Karunakaran, Parathan"' showing total 148 results

Search Constraints

Start Over You searched for: Author "Karunakaran, Parathan" Remove constraint Author: "Karunakaran, Parathan"
148 results on '"Karunakaran, Parathan"'

Search Results

3. Factors associated with thrombo-hemorrhagic deaths in patients with Acute Promyelocytic leukemia treated with Arsenic Trioxide and all-trans retinoic acid

10. Detection of serum M-protein in acetonitrile pecipitates by MALDI-TOF mass spectrometry: A novel, low-cost methodology

14. Long‐term real‐world outcomes of patients with acute promyelocytic leukaemia treated with arsenic trioxide and all‐trans retinoic acid without chemotherapy—a retrospective, single‐centre study

15. High-dose hydroxyurea with differentiating agents for treating ultra-high-risk acute promyelocytic leukemia in resource-challenged settings

17. Prognostic Factors and Outcomes of Adolescent and Adult Burkitt Lymphoma and Leukemiafrom a Low-Middle Income Country: An Experience from Hematology Cancer Consortium

18. Induction Related Mortality Score in Acute Myeloid Leukemia: Prospective Validation Study (pRISM) of the Hematology Cancer Consortium (HCC)

19. Low Dose Dasatinib Is Not As Active in a CML CP Cohort Enriched with Intermediate/High-Risk CML Chronic Phase: A Phase IIb Multi-Center Trial

21. P-146: Screening technique for M-proteins in acetonitrile precipitates of serum using MALDITOF mass spectrometry: a comparison with serum immunofixation electrophoresis and serum free light chain assay

24. Long‐term real‐world outcomes of patients with acute promyelocytic leukaemia treated with arsenic trioxide and all‐trans retinoic acid without chemotherapy—a retrospective, single‐centre study.

25. Therapeutic Outcomes in High-Grade B-Cell Lymphoma, NOS: Retrospective Analysis

26. Real-World Experience of Treating Pediatric Chronic Myeloid Leukemia: Retrospective Study from a Cancer Center in Southern India

29. Coronavirus Disease (COVID-19) Testing in Asymptomatic Patients Planned for Day Care Systemic Therapy: A Tertiary Cancer Center Experience

31. COVID19 in children with cancer in low- and middle-income countries: Experience from a cancer center in Chennai, India

32. Detection of M-Protein in Acetonitrile Precipitates of Serum Using MALDI-TOF Mass Spectrometry: A Novel Methodology

33. High-Grade B-Cell Lymphoma,NOS : Does Prognosis End with the Diagnosis? - a Retrospective Analysis

34. Haploidentical Hematopoietic Stem Cell Transplantation in Leukemia’s: Experience from a Cancer Center in India

35. Efficacy and toxicity of FLAG/IDA as salvage chemotherapy in pediatric relapsed acute leukemias: 8 year experience from a tertiary cancer centre

37. Olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy–induced vomiting in children: An open‐label, randomized phase 3 trial

39. Detection of M-Protein in Acetonitrile Precipitates of Serum using MALDI-TOF Mass Spectrometry

40. Letrozole and Palbociclib in Advanced Breast Cancer: Outcome from Cancer Institute, Chennai

41. Coronavirus disease (COVID-19) testing in asymptomatic patients planned for daycare systemic therapy: A tertiary cancer center experience

42. ABL Kinase Domain Mutation in Chronic Myeloid Leukemia - Compliance to Imatinib Matters

43. Plasmablastic Lymphoma - Experience with Infusional EPOCH Chemotherapy from India

44. A Synchronous Presentation of AITL with Adenocarcinoma of Lung

45. Adolescent and Young Adult Chronic Myeloid Leukemia in Real-World Settings: Experience from a Tertiary Care Institute in Northern India

46. COVID19 in children with cancer in low- and middle-income countries: Experience from a cancer center in Chennai, India.

49. Plasma Cell Leukemia Presenting with Hyperleukocytosis and Anaplasia

50. Mixed Phenotypic Acute Leukemia -Clinical Presentation, Prognosis and Outcomes of Patients Treated with Acute Lymphoblastic Leukemia like Protocols a Multi-Institutional Study from India

Catalog

Books, media, physical & digital resources